Primary Job Title Vice President, Global Market Access - Gene Therapy Primary Organization 
Audentes Therapeutics
Location Greater San Diego Area, California, United States Regions West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Mr. Slocomb has served as Vice President, Commercial Planning since January 2015. He has over 22 years of experience in the areas of new product and portfolio planning, marketing, corporate development and venture capital in the biotechnology and pharmaceutical industries, including significant experience developing and executing commercialization
strategies for biopharmaceuticals in rare diseases. Before joining Audentes, Mr. Slocomb was Senior Director, Corporate Development for Fate Therapeutics, which is developing stem cell therapies for rare hematologic and muscle disorders. Mr. Slocomb also spent over seven years at Amylin Pharmaceuticals, Inc. in new product commercialization leadership roles, including leading the creation and execution of the commercialization strategy for MYALEPT® (metreleptin for injection) for rare lipodystrophy.
Prior to his position at Amylin, Mr. Slocomb held roles of increasing responsibility in healthcare strategy consulting, strategic planning and marketing in the pharmaceutical industry and as the Principal of a healthcare venture capital fund.
Mr. Slocomb earned a B.A. in Genetics from the University of California, Berkeley and a M.B.A. from the Leonard N. Stern School of Business at New York University, where he was a Stern Scholar.
